Hemangiopericytoma

This is a type of rare tumor. It starts in cells around small blood vessels. It can be harmless (benign) or harmful (malignant). Doctors sometimes find it hard to tell which type it is because it's so uncommon.

Condition

What people with Hemangiopericytoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Radiation Therapy for Hemangiopericytoma?

NameHow it went

About Hemangiopericytoma

What It Is

Hemangiopericytoma is an older name for a rare tumor that doctors now call a solitary fibrous tumor. It grows from connective tissue cells and is threaded with many branching blood vessels, which is why it was once thought to come from the cells that wrap around small blood vessels. Pathologists later found that these tumors share a specific gene change with solitary fibrous tumors, so the two names were merged. The term hemangiopericytoma was dropped for soft tissue tumors in 2013 and for brain and spinal tumors in 2021, but many people still see it on older reports or in conversation. The tumor can form almost anywhere: in the lining of the lungs, deep in the abdomen or pelvis, in the arms and legs, in the head and neck, or in the membranes that cover the brain and spinal cord. It usually grows slowly as a painless lump, and symptoms come from pressure on nearby structures. A tumor in the chest may cause cough, chest pain or shortness of breath, though many are found by chance on a scan. One in the abdomen may cause bloating, constipation or trouble passing urine. One near the brain may cause headaches or other signs of pressure inside the skull. Rarely, a large tumor releases a hormone that lowers blood sugar, causing episodes of shakiness, sweating or confusion. Most of these tumors behave in a slow, low-grade way, but some return after treatment or spread to other parts of the body, sometimes many years later. That range of behavior, rather than a simple benign or malignant label, is what shapes treatment and follow-up.

Causes & Risk Factors

The tumor is driven by a change in the cells' DNA in which two genes, NAB2 and STAT6, become fused. The fused gene switches on growth signals that normally stay off, and it is found in nearly all of these tumors. Why the change happens is not known, and there is no known way to prevent it. The tumor mostly affects adults, most often between about 40 and 70, and occurs about equally in men and women. Older age is the main recognized risk factor. A diagnosis does not mean someone did something to cause it.

How It's Diagnosed

Imaging is usually the first step. CT or MRI shows a well-defined mass, often with a rich blood supply, and helps map its size and its relationship to nearby organs. Imaging cannot confirm what the tumor is. In the brain, for example, it can look almost identical to a meningioma, a much more common and usually less aggressive tumor of the brain's covering. The diagnosis is made by examining tumor tissue, from a biopsy or after the tumor is removed. Pathologists look at the pattern of cells and vessels and use a stain for STAT6, a protein that shows up in the cell nucleus when the NAB2 and STAT6 genes are fused, along with a second marker called CD34. Together these confirm the diagnosis in most cases, and genetic testing can help when results are unclear. The pathologist also estimates how aggressive the tumor is likely to be. Outside the brain, doctors commonly combine the person's age, the tumor's size (5 cm or larger places it in a higher risk category) and how many cells are dividing to sort tumors into low, intermediate or high risk of spread. Tumors in the brain and spinal cord are graded 1 to 3 instead; grade 3 corresponds to what was once called anaplastic hemangiopericytoma. A small number of tumors are dedifferentiated, meaning part of the tumor has turned into a fast-growing, high-grade cancer.

Treatment Options

Surgery to remove the whole tumor with a rim of healthy tissue around it is the main treatment and the best chance of long-term control. When removal is complete, many people need no other treatment. If tumor cells remain at the edge of what was removed, a second operation may be considered when it can be done safely. Because these tumors are rare and have a rich blood supply, care is best planned by a team experienced with sarcomas, the broader family of connective tissue cancers that this tumor belongs to. Radiation therapy is often added after surgery for higher-risk tumors, tumors that could not be fully removed, and higher-grade tumors in the brain. It lowers the chance of the tumor growing back in the same place, although studies have not shown that it helps people live longer. Radiation is sometimes given before surgery or used when an operation is not possible. When the tumor has spread or cannot be removed, a few spots that can be reached may still be treated with surgery, radiation or other local treatments. Standard sarcoma chemotherapy shrinks these tumors in only a minority of people and more often just holds them steady. Medicines that cut off a tumor's blood supply tend to work better for the usual, non-dedifferentiated type. Pazopanib (Votrient) is the most studied: a daily tablet approved for advanced soft tissue sarcoma after chemotherapy. It needs regular blood tests because it can seriously damage the liver. Dedifferentiated tumors are more often treated with chemotherapy first. Since no option reliably controls advanced disease, a clinical trial is worth asking about whenever medicine is needed.

What to Expect

The outlook depends mostly on where the tumor is, its risk group or grade, and whether it was completely removed. Many people with a fully removed, lower-risk tumor return to normal life and simply continue follow-up. Recovery from surgery depends mainly on where the tumor was and how extensive the operation needed to be. Follow-up is long because these tumors can come back late. Recurrence or spread is less common after a low-risk tumor outside the brain, but over long follow-up it becomes common for higher-risk tumors and for tumors in the brain's covering, even at grade 1. It can happen more than 10 to 15 years after treatment, and when it spreads it usually goes to the lungs, bones or liver. Expect periodic scans for many years, with how often and what they cover set by the tumor's location and risk. For people living with advanced disease, the tumor often grows more slowly than other spread sarcomas, and treatment usually aims to keep it stable for as long as possible rather than eliminate it. Treatment decisions tend to be revisited over time as scans change and side effects add up.

When to Seek Help

See a doctor about a new lump that is growing, or about ongoing cough, chest pain, abdominal fullness, or headaches that are new and persistent. After treatment, keep to the scan schedule even when you feel well, and report a new lump, cough or bone pain to your care team, since these can be early signs of the tumor returning. In someone with a tumor in or near the brain, a seizure (especially a first one, one lasting more than a few minutes, or one after which the person does not wake up normally), or sudden weakness, numbness, trouble speaking or a sudden severe headache, needs emergency care: call 911. Headaches or vision changes that come on gradually or keep getting worse need assessment by the care team the same day. Because large tumors can rarely drive blood sugar down, report repeated episodes of shakiness, sweating, dizziness or confusion, especially when you have not eaten, to your care team right away. During an episode, eat or drink something sugary if you can swallow safely. Someone who passes out or cannot be woken needs emergency care: call 911.

Questions to Ask Your Doctor

  1. 1.Does my pathology report confirm a solitary fibrous tumor, and what risk group or grade was it given?
  2. 2.Was the whole tumor removed with clear edges, and would radiation or another operation lower my chance of it coming back?
  3. 3.Is my care being reviewed by a team that treats sarcomas, and should I get a second opinion at a specialist center?
  4. 4.How often will I need scans, which parts of my body will they cover, and for how many years?
  5. 5.If the tumor comes back or spreads, which treatments or clinical trials would make sense for my type?

Last reviewed • Oct 2026

Educational content, not medical advice.